natgillin/translations-raw huggingface dataset:
0.75 VN. U*
0, 75 VN. U *
Vironeutralising antibody titre after vaccine injection in guinea pigs
Vironevtralizcijski titer protiteles po cepljenju pri morskih prašičkih
5 doses (bottle of 10 ml)
5 odmerkov (steklenička 10 ml)
EXP {month/ year} Once broached, use within 6 hours.
EXP {mesec/ leto} Načeto zdravilo uporabite v šestih urah
Cattle Accidental injection is dangerous – see package insert before use.
Govedo Nenamerno injiciranje je nevarno - pred uporabo preberite priložena navodila
29/ 35 MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS
29/ 35 PODATKI, KI OVOJNINAH
10 doses (bottle of 20 ml)
10 odmerkov (steklenička 20 ml)
30/ 35 MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS
30/ 35 PODATKI, KI OVOJNINAH
25 doses (bottle of 50 ml)
25 odmerkov (steklenička 50 ml)
32/ 35 PACKAGE INSERT
32/ 35 NAVODILO ZA UPORABO
STATEMENT OF THE ACTIVE AND OTHER SUBSTANCE(S)
NAVEDBA ZDRAVILNE UČINKOVINE IN DRUGE( IH) SNOVI
Each 2-ml dose of vaccine contains: gE deleted inactivated IBR virus, at least
Vsak odmerek po 2 ml vsebuje: inaktivirani virus IBR z delecijo gE, najmanj 0, 75 VN. U * adjuvans: lahko parafinsko olje 449, 6 do 488, 2 mg * VN. U: vironevtralizcijski titer protiteles po cepljenju pri morskih prašičkih
Marketing authorisation holder MERIAL 29 avenue Tony Garnier F-69007 LYON France
MERIAL 29 avenue Tony Garnier F- 69007 LYON Francija
Manufacturing authorisation holder responsible for batch release Merial Laboratoire Porte des Alpes Rue de l'Aviation F-69800 Saint Priest France
Imetnik dovoljenja za proizvodnjo zdravila, odgovoren za sprostitev serije Merial Laboratoire Porte des Alpes Rue de l' Aviation F- 69800 Saint Priest Francija
Inject one 2-ml dose of vaccine by subcutaneous route according to the following regimen:
Injicirajte en odmerek (2 ml) v podkožje po naslednjem režimu:
33/ 35 The presence of maternally derived antibodies against infectious bovine rhinotracheitis virus may interfere with the vaccination and requires an appropriate vaccination regimen.
33/ 35 Prisotnost maternalnih protiteles proti IBR virusu lahko vpliva na uspešnost cepljenja, zato je potreben poseben program cepljenja
Basic vaccination: two injections 21 days apart.
Osnovno cepljenje:
For use in animals from the age of 2 weeks in the absence of maternally derived antibodies against IBR virus or from the age of 3 months in the presence of maternally derived antibodies.
Cepimo živali, starejše od 2 tednov, ki nimajo
Revaccination: a booster injection should be administered at 6 month intervals.
Revakcinacija:
• Allow the vaccine to reach a temperature of 15 -25ºC. • Shake well prior to use • Subcutaneous use
Pustite, da se cepivo segreje na temperaturo 15 – 25 oC.
• Injection in the neck at the front of the shoulder. • Use sterile syringes and needles.
- Injicirajte v predel vratu na prednjem delu rame.
Ibraxion is a gene specific deleted (gE), inactivated and adjuvanted (o/ w emulsion) vaccine which acts by the active immunisation of cattle characterised by the production of Infectious Bovine Rhinotracheitis (IBR) vironeutralising antibodies.
Ibraxion je cepivo, ki ima delecijo specifičnega gena (gE).
The gE gene deletion allows differentiation between animals vaccinated with gE-negative vaccines (anti gE antibody negative, IBR vironeutralising antibody positive) and naturally infected animals (positive to both IBR vironeutralising antibody and anti gE antibody).
Je inaktivirano pomožno (o/ v emulzija) cepivo, ki aktivno imunizira govedo tako, da ustvarja vironevtralizirajoča protitelesa proti kužnemu govejemu rinotreheitisu (IBR). gE genska delecija omogoča razlikovanje med živalmi, ki so bile cepljene z gE negativnim cepivom (proti gE protitelesa negativne, IBR vironevtralizirajoča protitelesa pozitivne), in naravno okuženimi živalmi (pozitivne na ena in druga; IBR vironevtralizirajoča protitelesa in proti gE protitelesa).
• The injection of the vaccine may cause a transient tissue reaction at the site of injection, which may persist for three weeks and rarely up to five weeks. • The vaccination may cause a slight rise in body temperature (less than 1°C) for a transient period (less than 48 hours after injection) without any consequence to the health or performance of the animal. • A hypersensitivity reaction may occur.
(manj kot 48 ur po vnosu) brez kakršnihkoli posledic za zdravje ali proizvodno sposobnost živali.
These are rare and an appropriate • symptomatic treatment should be administered. • If you notice any other side effects, please inform your veterinary surgeon.
- Če opazite kakršnekoli druge stranske učinke, obvestite svojega veterinarja.
• Keep out of the reach and sight of children • Store at 2°C – 8°C (in a refrigerator), protected from light.
Cepivo ne sme zmrzniti.
Do not freeze. • Use within the six hours after first opening of the container. • Do not use after the expiry date stated on the label.
Zdravila ne smete uporabljati po datumu izteka roka uporabnosti, navedenega na nalepki
• Vaccinate only healthy animals. • Do not mix with any other medicinal product.
Ne mešajte z nobenim drugim zdravilom.
The import, sale, supply and/ or use of this veterinary medicinal product is or may be prohibited in certain Member States on the whole or part of their territory pursuant to national animal health policy.
Uvoz, prodaja, oskrba in/ ali uporaba tega zdravila za uporabo v veterinarski medicini je, ali je lahko, zaradi programa nacionalnega zdravstvenega varstva živali prepovedana v nekaterih državah članicah na njihovem celotnem ozemlju ali delu ozemlja.
Any person intending to import, sell, supply and/ or use the veterinary medicinal product must consult the relevant Member State’ s Competent Authority on the current vaccination policies prior to the import, sale, supply and/ or use
Kdor želi uvoziti, prodajati, oskrbovati in/ ali uporabljati zdravilo za uporabo v veterinarski medicini, se mora pred uvozom, prodajo, oskrbo in/ ali uporabo tega zdravila posvetovati s pristojnim organom države članice o trenutnem programu cepljenja.
Veterinary medicinal product subject to prescription
Zdravilo se izdaja samo na recept
Blister
pretisni
Box containing N/ a 1 blister
Zloženka z 1 N/ a pretisnim omotom
Incurin is used for the treatment of hormone-dependent urinary incontinence resulting from sphincter mechanism incompetence (SMI) in ovariohysterectomised bitches (i. e. in dogs having had the ovaries and uterus removed surgically).
Zdravilo Incurin se uporablja za zdravljenje hormonsko odvisne urinske inkontinence, ki je posledica nepravilnega delovanja sfinkterskega mehanizma pri psicah po ovariohisterektomiji (tj. pri psicah, ki so jim kirurško odstranili jajčnike in maternico).
Animals showing a polyuria-polydipsia (excessive water intake and consequent excretion of a large volume of urine) should also not be treated with this product.
Živali s poliurijo- polidipsijo (pretiran vnos vode in posledično izločanje velikih količin urina) se prav tako ne sme zdraviti s tem zdravilom.
Effects typical to oestrogens such as swollen vulva, swollen mammary glands and/ or attractiveness to males and vomiting have been observed at the highest recommended dose of 2 mg per dog.
Po dajanju največjega priporočenega odmerka, ki je 2 mg na eno psico, so bili opaženi učinki, značilni za estrogen, kot so nabrekla zunanja spolovila, nabrekle mlečne žleze, privlačnost za samca in bruhanje.
The incidence is about 5-9%.
Pogostost teh pojavov je okoli 5 do 9%.
The European Commission granted a marketing authorisation valid throughout the European Union for Incurin to Intervet International B. V. on 24 March 2000 and renewed in it 2005.
Evropska komisija je dovoljenje za promet z zdravilom Incurin, veljavno po vsej Evropski uniji, odobrila družbi Intervet International B. V. dne 24. marca 2000 in ga podaljšala leta 2005.
This summary was last updated in April 2008.
Povzetek je bil nazadnje posodobljen 04- 2008.
Active substance: estriol 1 mg/ tablet For a full list of excipients, see section 6.1
Zdravilna učinkovina: estriol, 1 mg v eni tableti Za celoten seznam pomožnih snovi, glejte poglavje 6. 1.
Tablet Round single-scored tablets.
Tableta Okrogle tablete z zarezo na eni strani.
The treatment of hormone-dependent urinary incontinence due to sphincter mechanism incompetence in ovariohysterectomised bitches.
Zdravljenje hormonsko odvisne urinske inkontinence, ki je posledica nepravilnega delovanja sfinkterskega mehanizma pri psicah po ovariohisterektomiji
Animals showing a polyuria-polydipsia should not be treated with Incurin.
Živali s sindromom poliurije- polidipsije ne smemo zdraviti z Incurinom.
The use of Incurin is contraindicated during pregnancy and in animals younger than 1 year.
Uporaba Incurina je kontraindicirana v obdobju brejosti in pri živalih, mlajših od 1 leta.
4.5 Special precautions for use
Posebni previdnostni ukrepi za uporabo pri živalih
Special precautions for use in animals In case of oestrogenic effects, the dose should be lowered.
Če se pojavijo estrogeni učinki, moramo zmanjšati odmerek.
Oestrogenic effects such as swollen vulva, swollen mammary glands and/ or attractiveness to males and vomiting have been observed at the highest recommended dose of 2 mg per dog.
Po dajanju največjega priporočenega odmerka, ki je 2 mg na psico, so zasledili estrogene učinke, kot so nabrekla zunanja spolovila, nabrekle mlečne žleze ali privlačnost za samca, in bljuvanje.
The incidence is about 5- 9%.
Pogostnost teh pojavov je približno 5 do 9%.
In very rare cases development of alopecia has also been observed.
Zasledili so še zelo redki primere razvoja alopecije.
2/ 15 4.7 Use during pregnancy, lactation or lay
2/ 15 4. 7 Uporaba v obdobju brejosti, laktacije ali nesnosti
4.9 Amount(s) to be administered and administration route
4. 9 Odmerjanje in pot uporabe
The minimum dose given should not be less than 0.5 mg per dog per day.
Najmanjši odmerek ne sme biti manjši od 0, 5 mg na dan na psico.
4.11 Withdrawal periods
4. 11 Karenca
Pharmacotherapeutic group: estrogens, ATCvet code:
Farmakoterapevtska skupina: estrogeni, oznaka ATCvet:
Amylopectin Potato starch Magnesium stearate
Amilopektin Krompirjev škrob Magnezijev stearat
3/ 15 Lactose
3/ 15 Laktoza
6.2 Imcompatibilities
6. 2 Inkompatibilnosti
6.6 Special precautions for the disposal of unused medicinal product or waste materials derived from the use of such products
6. 6 Posebni varnostni ukrepi za odstranjevanje neporabljenega zdravila ali odpadnih snovi
Date of first authorisation:
Datum prve odobritve: marec 2000 Datum podaljšanja: februar 2005
March 2000 Date of renewal of the authorisation:
PREPOVED PRODAJE, OSKRBE IN/ ALI UPORABE
4/ 15 ANNEX II
4/ 15 DODATEK II
6/ 15 ANNEX III
6/ 15 DODATEK III
8/ 15 PARTICULARS TO APPEAR ON THE OUTER PACKAGE
8/ 15 PODATKI NA ZUNANJI
Carton box
Zloženka
STATEMENT OF ACTIVE AND OTHER SUBSTANCES
IME ZDRAVILA ZA UPORABO V VETERINARSKI MEDICINI
Active substance: estriol 1 mg/ tablet
INCURIN 1 mg, tableta
INDICATION(S)
INDIKACIJ( A) E
Dosage and administration: see enclosed leaflet.
Za peroralno uporabo Odmerjanje in način uporabe: glejte priloženo navodilo.
Exp (Month/ year)
EXP {mesec/ leto}
SPECIFIC PRECAUTIONS FOR THE DISPOSAL OF UNUSED PRODUCT OR WASTE MATERIAL, IF ANY
POSEBNI VARNOSTNI UKREPI ZA ODSTRANJEVANJE NEPORABLJENEGA ZDRAVILA ALI ODPADNIH SNOVI, ČE OBSTAJAJO
MA number.
Številka dovoljenja za promet:
Batch number.
Številka serije
10/ 15 PARTICULARS TO APPEAR ON THE IMMEDIATE PACKAGE
10/ 15 PODATKI, KI MORAJO BITI NAVEDENI NA STIČNI OVOJNINI
Blister of 30 tablets
Pretisni omot s 30 tabletami
(Month / year)
Mesec/ leto
THE WORDS “ FOR ANIMAL TREATMENT ONLY”
BESEDILO » SAMO ZA ŽIVALI «
NAME AND ADDRESS OF THE MARKETING AUTHORSATION HOLDER AND OF THE MANUFACTURING AUTORISATION HOLDER RESPONSIBLE FOR BATCH RELEASE, IF DIFFERENT
IME IN NASLOV IMETNIKA DOVOLJENJA ZA PROMET Z ZDRAVILOM TER IMETNIKA DOVOLJENJA ZA PROIZVODNJO ZDRAVILA, ODGOVORNEGA ZA SPROSTITEV SERIJ, ČE STA RAZLIČNA
INCURIN 1 mg tablet Estriol
INCURIN 1 mg, tableta
STATEMENT OF THE ACTIVE SUBSTANCE(S) AND OTHER INGREDIENTS
NAVEDBA ZDRAVILNE( IH) UČINKOVIN( E) IN DRUGE( IH) SESTAVIN
Active substance: estriol 1 mg/ tablet Round single-scored tablets.
Zdravilna učinkovina: estriol 1 mg v eni tableti Okrogle tablete z zarezo na eni strani.
Incurin is indicated for the treatment of hormone-dependent urinary incontinence due to sphincter mechanism incompetence in female dogs.
Incurin je indiciran za zdravljenje hormonsko odvisne urinske inkontinence, ki je posledica nepravilnega delovanja sfinkterskega mehanizma pri psicah po ovariohisterektomiji.
Mild, oestrogenic effects such as swollen vulva, swollen teats and/ or attractivity for males have been observed at the high dose of 2 mg.
Po dajanju velikega odmerka, po 2 mg, so zasledili blage, estrogene učinke, kot so nabrekanje zunanjih spolovil, nabrekanje mlečnih žlez ali privlačnost za samca.
Further, in some dogs, symptoms of nausea were observed.
Pri nekaterih psicah so se pojavili simptomi slabosti..
Because of its short-acting oestrogenic properties, Incurin does not induce bone marrow suppression in the dog.
Redko se je pojavila krvavitev iz nožnice.
If you notice any serious effects or other effects not mentioned in this leaflet, please inform your veterinary surgeon.
13/ 15 Če opazite kakršne koli resne stranske učinke ali druge učinke, ki niso omenjeni v teh navodilih za uporabo, obvestite svojega veterinarja.
High doses of oestrogen may have a tumor-promoting effect in target organs with oestrogen receptors (mammary glands).
Veliki odmerki estrogena lahko spodbudijo rast tumorja na ciljnih organih z estrogenskimi receptorji (mlečna žleza).
In case of overdose typcial oestrogen effects may occur.
Preveliki odmerki lahko imajo značilne estrogene učinke.
Upon oral administration a steady state is reached after the second treatment day and no accumulation occurs after multiple dosing.
Pri večkratnem dajanju ne prihaja do kopičenja zdravila.
Because of its short acting action, oestriol does not induce bone marrow suppression in the dog.
Zaradi kratkotrajnega delovanja estriol pri psicah ne povzroča supresije kostnega mozga..
When a pig is given the vaccine, the pig’ s immune system recognises the protein as ‘ foreign’ and reacts by building up an active immune response.
Ko prašiča cepimo, njegov imunski sistem prepozna beljakovino kot „ tujo “ in se nanjo odzove z aktiviranjem imunskega odziva.
7 Westferry Circus, Canary Wharf, London E14 4HB, UK Tel.
Te študije so bile opravljene v laboratoriju ter v tipičnih okoliščinah evropskega 7 Westferry Circus, Canary Wharf, London E14 4HB, UK Tel.
Reproduction is authorised provided the source is acknowledged How has Ingelvac CircoFLEX been studied?
Reproduction is authorised provided the source is acknowledged kmetijstva.
The benefit-risk balance may be found in module 6 of this EPAR.
Razmerje med koristmi in tveganji je v modulu 6 tega evropskega javnega poročila o oceni zdravila (EPAR).
EU - Number
EU - številka
Porcine circovirus type 2 ORF2 protein Minimum RP 1.0, Maximum RP 3.75
beljakovina ORF2 suspenzija za prašičjega injiciranje cirkovirusa tipa 2 najmanj 1, 0 RP največ 3, 75 RP
1 bottle
1 plastenka nič dni
Each dose of 1 ml of inactivated vaccine contains:
En odmerek po 1 ml inaktiviranega cepiva vsebuje:
Porcine circovirus type 2 ORF2 protein: minimum RP* 1.0 maximum RP* 3.75 * Relative Potency (ELISA test) by comparison with a reference vaccine
beljakovina ORF2 prašičjega cirkovirusa tipa 2: najmanj 1, 0 RP * največ 3, 75 RP * * relativna učinkovitost (preskus ELISA) v primerjavi z referenčnim cepivom
Carbomer
karbomer
Pigs (from 2 weeks of age)
Prašiči (od starosti 2 tednov)
For active immunisation of pigs over the age of 2 weeks against Porcine Circovirus Type 2 (PCV2) to reduce mortality, clinical signs - including weight loss - and lesions in lymphoid tissues associated with PCV2 related disease (PCVD).
Za aktivno imunizacijo prašičev od starosti 2 tednov proti prašičjemu cirkovirusu tipa 2 (PCV2) z namenom zmanjšati smrtnost, klinične znake - tudi hujšanje - in poškodbe v limfnih tkivih, ki jih povzročajo bolezni zaradi okužbe s PCV2 (PCVD).
Onset of protection occurs as early as 2 weeks post vaccination and lasts for at least 17 weeks.
Zaščitni učinek se razvije že 2 tedna po cepljenju in traja najmanj 17 tednov.
2 Special precautions to be taken by the person administering the veterinary medicinal product to animals
2 Posebni previdnostni ukrepi, ki jih mora izvajati oseba, ki živalim daje zdravilo
No information is available on the compatibility of this vaccine with any other.
Ni podatkov o varnosti ter učinkovitosti ob sočasni uporabi tega cepiva s katerim koli drugim cepivom.
Therefore the safety and efficacy of this product when used with any other (either when used on the same day or at different times) has not been demonstrated.
Zato njegova varnost in učinkovitost ob sočasni uporabi s katerim koli drugim cepivom (isti dan ali ob različnih časih) nista dokazani.
Single intramuscular injection of one dose (1 ml), irrespective of body weight.
Enkratni odmerek (1 ml) intramuskularno ne glede na telesno maso.
Use vaccination devices according to the manufacturer's instruction.
Opremo za cepljenje uporabljajte v skladu z izdelovalčevimi navodili.
Following the administration of a 4-fold overdose of vaccine no adverse reactions other than those described under section 4.6. have been observed.
Po dajanju 4- krat prevelikega odmerka cepiva niso zasledili neželenih učinkov, ki bi se razlikovali od tistih, ki so opisani v poglavju 4. 6.
Inactivated Porcine circovirus vaccine
inaktivirano cepivo s prašičjim cirkovirusom
ATC vet code:
Oznaka ATC vet:
This vaccine is designed to stimulate the development of an active immune response to Porcine circovirus type 2.
Cepivo je namenjeno za spodbujanje razvoja aktivnega imunskega odziva na prašičji cirkovirus tipa 2.
6.1 List of excipients
natrijev klorid voda za injekcije
Sodium chloride Water for injection
3 6. 2 Inkompatibilnosti
3 6.2 Incompatibilities
6. 3 Rok uporabnosti
Do not mix with any other vaccine or immunological product.
Rok uporabnosti zdravila v pakiranju za prodajo:
15 months.
15 mesecev.
Use immediately after opening.
Uporabite takoj po odpiranju.
High density polyethylene bottles of 10 ml, 50 ml, 100 ml or 250 ml with a chlorobutyl stopper and lacquered aluminium seal.
Plastenke iz polietilena visoke gostote po 10 ml, 50 ml, 100 ml ali 250 ml z zamaški iz klorobutila in zaporkami iz lakiranega aluminija.
Each bottle is packed individually in a cardboard box.
Plastenke so posamično pakirane v kartonaste škatle.
Boehringer Ingelheim Vetmedica GmbH 55216 Ingelheim/ Rhein Germany
Boehringer Ingelheim Vetmedica GmbH 55216 Ingelheim/ Rhein Nemčija
The import, sale supply and/ or use of Ingelvac CircoFLEX is or may be prohibited in certain Member States on the whole or part of their territory pursuant to national animal health policy.
Uvoz, prodaja, oskrba in/ ali uporaba cepiva CircoFLEX je ali je lahko prepovedana v nekaterih državah članicah na njihovem celotnem ozemlju ali delu ozemlja v skladu z nacionalnim programom zdravstvenega varstva živali.
Any person intending to import, sell, supply and/ or use Ingelvac CircoFLEX must consult the relevant Member State's competent authority on the current vaccination policies prior to the import, sale, supply and/ or use.
Vsakdo, ki namerava uvažati, prodajati, oskrbovati in/ ali uporabljati Ingelvac CircoFLEX, se mora posvetovati s pristojnimi organi posamezne države članice o veljavnih programih cepljenja še pred uvozom, prodajo, oskrbo in/ ali uporabo.
Name and address of the manufacturer(s) of the biological active substance(s) Boehringer Ingelheim Vetmedica Inc.
Ime in naslov izdelovalca( izdelovalcev) biološke zdravilne učinkovine (zdravilnih učinkovin) Boehringer Ingelheim Vetmedica Inc.
Joseph, Missouri, 64506 U. S. A.
Joseph, Missouri, 64506 ZDA
Name and address of the manufacturer(s) responsible for batch release Boehringer Ingelheim Vetmedica GmbH 55216 Ingelheim/ Rhein GERMANY
Ime in naslov izdelovalca( izdelovalcev) zdravila, odgovornega za sproščanje serije Boehringer Ingelheim Vetmedica GmbH 55216 Ingelheim/ Rhein NEMČIJA
The holder of this marketing authorisation must inform the European Commission about the marketing plans for the medicinal product authorised by this decision.
Imetnik dovoljenja za promet mora obvestiti Evropsko komisijo o načrtih trženja zdravila, za katerega je bila izdano to dovoljenje za promet.
Sodium chloride is included in Annex II of Council Regulation (EEC) No 2377/ 90 in accordance with the following table:
2377/ 90 kot je navedeno v tabeli:
Pharmacologically active substance(s)
Živalska vrsta
Animal species
Druge določbe
Other provisions
aktivna( e) snov( i)
All food-producing species
vse živalske vrste za proizvodnjo živil
Carbomer is considered not within the scope of Council Regulation (EEC) No.
Za karbomer velja, da ni vključen v Uredbo sveta (EGS) št.
{10 ml; 50 ml, 100 ml, 250 ml cardboard box}
{10 ml, 50 ml, 100 ml, 250 ml, kartonska škatla}
Porcine circovirus type 2 ORF2 protein Carbomer
En odmerek inaktiviranega cepiva vsebuje: beljakovino ORF2 prašičjega cirkovirusa tipa 2 karbomer
For active immunisation of pigs over the age of 2 weeks against Porcine Circovirus Type 2 (PCV2).
Za aktivno imunizacijo prašičev od starosti 2 tednov proti prašičjemu cirkovirusu tipa 2 (PCV2).
Single intramuscular injection of one dose (1 ml) Read the package leaflet before use.
Enkratni odmerek intramuskularno (1 ml) Pred uporabo preberite navodilo za uporabo.
Withdrawal period:
Karenca: nič dni.
EXP {month/ year} Use immediately after opening.
EXP {mesec/ leto} Uporabite takoj po odpiranju.
Store and transport refrigerated (2 °C - 8 °C).
Shranjujte in prevažajte v hladilniku (2 °C – 8 °C).
Boehringer Ingelheim Vetmedica GmbH D-55216 Ingelheim/ Rhein
Boehringer Ingelheim Vetmedica GmbH D- 55216 Ingelheim
11 PARTICULARS TO APPEAR ON THE IMMEDIATE PACKAGE
PRIMARNI OVOJNINI
{100 ml, 250 ml bottle}
{plastenka po 100 ml, 250 ml}
Read the package leaflet before use.
Enkratni odmerek intramuskularno (1 ml) Pred uporabo preberite navodilo za uporabo.
Boehringer Ingelheim Vetmedica GmbH Germany
Boehringer Ingelheim Vetmedica GmbH Nemčija
{10 ml, 50 ml bottle}
{plastenka po 10 ml, 50 ml}
15 PACKAGE LEAFLET FOR:
15 NAVODILO ZA UPORABO
STATEMENT OF THE ACTIVE SUBSTANCE(S) AND OTHER INGREDIENTS
NAVEDBA ZDRAVILNE( IH) UČINKOVIN( E) IN DRUGEIH SESTAVIN
Carbomer
En odmerek po 1 ml inaktiviranega cepiva vsebuje: beljakovino ORF2 prašičjega cirkovirusa tipa 2: najmanj 1, 0 RP *, največ 3, 75 RP * * relativna učinkovitost (preskus ELISA) v primerjavi z referenčnim cepivom Dodatek: karbomer
For active immunisation of pigs over the age of 2 weeks against Porcine Circovirus Type 2 (PCV2) to reduce mortality, clinical signs - including weight loss - and lesions of in lymphoid tissues associated with PCV2 related diseases (PCVD).
Za aktivno imunizacijo prašičev od starosti 2 tednov proti prašičjemu cirkovirusu tipa 2 (PCV2) z namenom zmanjšati smrtnost, klinične znake - tudi hujšanje - in poškodbe v limfnih tkivih, ki jih povzročajo bolezni zaradi okužbe s PCV2 (PCVD).
Onset of immunity:
Zaščitni učinek:
as early as 2 weeks post vaccination at least 17 weeks.
že 2 tedna po cepljenju najmanj 17 tednov
Single intramuscular(IM) injection of one dose (1 ml) to pigs, irrespective of body weight.
Enkratni odmerek (1 ml) intramuskularno (i. m.) prašičem ne glede na telesno maso.
Use vaccination devices according to the manufacturer's instructions.
Opremo za cepljenje uporabljajte v skladu z izdelovalčevimi navodili.
Avoid multiple vial broaching.
Izogibajte se večkratnega odpiranja.
Precautions for use in animals Avoid introduction of contamination during use.
Posebni previdnostni ukrepi za uporabo pri živalih Pazite, da med uporabo ne bi prišlo do kontaminacije.
Use during pregnancy and lactation Do not use during pregnancy and lactation.
Uporaba v obdobju brejosti in laktacije Ne uporabite v obdobju brejosti in laktacije.
Incompatibilities No safety or efficacy information is available on the compatibility of this vaccine with any other vaccine.
Inkompatibilnosti Ni podatkov o varnosti in učinkovitosti glede kompatibilnosti tega cepiva s katerim koli drugim cepivom.